Category: neuroendocrine tumors

Endocrinology Society Recognizes Neuroendocrine Cancer Physician and Researcher for Excellence at 2018 Annual Meeting

April 15, 2018

When Amit Tirosh, MD came to the United States in 2015 to be a senior endocrinologist at the National Institutes of Health (NIH), he began a journey that will lead full circle when he returns to Israel this summer to establish and lead a new neuroendocrine

READ MORE
Edward Wolin, MD joins Markey Cancer Center as Director of the Carcinoid and Neuroendocrine Tumor Program

June Luncheon with the Experts in New York City for the Neuroendocrine Tumor Community

April 3, 2018

Join neuroendocrine tumor (NET) patients in New York City on Sunday, June 10, 2018 for a unique opportunity to have lunch with two medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues ranging…

READ MORE

Zebra Tales: Carcinoid NETs Health Storylines Launches New Feature

February 15, 2018

Carcinoid NETs Health Storylines presents Zebra Tales! This brand new feature enables you to learn and share more about the experiences of others within the neuroendocrine tumor (NET) community.

Our first inspiring story is from Stacie Chevrier –…

READ MORE

FDA Approves LUTATHERA® for Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

January 26, 2018

BREAKING NEWS: On January 26, 2018 the US Food and Drug Administration approved LUTATHERA® marking the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of gastroenteropancreatic neuroendocrine tumors

READ MORE

News about Neuroendocrine Cancer Expert Physicians

January 8, 2018

Three appointments and a newly established one-year neuroendocrine tumor (NET) fellowship herald an exciting new year for several NET specialists.

Dr. Edward M. Wolin

Edward M. Wolin, MD, Co-Medical Director of the Carcinoid Cancer Foundation, has…

READ MORE
The late Monica Warner, a pioneer in carciniod and NET cancer patient advocacy

8th Annual Warner Advocacy Award: Call for Nominations

November 14, 2017

Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize…

READ MORE

Nutrition for Neuroendocrine Tumors and Carcinoid Syndrome: Find Foods You Love!

October 11, 2017

Are you wondering what are the best foods to eat if you have carcinoid syndrome?  What changes should you make to your diet if you have neuroendocrine tumors? The neuroendocrine tumor (NET) community is invited to attend a national webcast on Wednesday,

READ MORE

New Market Research Study Seeking Neuroendocrine Tumor and Carcinoid Syndrome Patient Participants

July 5, 2017

Foster Rosenblatt, a leading provider of oncology patient data, is seeking participants in the United States for both telephone interviews and an online survey for neuroendocrine tumor patients who have been clinically diagnosed with a gastrointestinal…

READ MORE

Acronyms Used in the Carcinoid and Neuroendocrine Tumor Community

April 19, 2017

Whether you are newly diagnosed, a friend or family member of a carcinoid/neuroendocrine tumor (NET) patient, or someone living with the disease for a long time, the language used in the carcinoid/NET community, especially the acronyms, can seem like…

READ MORE

Carcinoid NETs Health Storylines — Now Available in Seven Countries

April 17, 2017
 Are you from the UK, Ireland, Australia, New Zealand, or Singapore? A new self-care management tool for Carcinoid and Neuroendocrine Tumors (NETs) is now available for you!

The Carcinoid Cancer Foundation (CCF) and our partner Self Care Catalysts (SCC)

READ MORE